ABSTRACT. As a heterogeneous group of disorders in pregnancy, many genetic factors are involved in the development of preeclampsia. The single nucleotide polymorphism (SNP) rs7579169, located on chromosome 2q14.2, has been shown to be associated with pregnancyinduced hypertension in Europeans. In this study, we examined whether the SNP rs7579169 is associated with the susceptibility to preeclampsia through a case-control research model in Han Chinese women. Genotypes of 145 patients with preeclampsia and 150 healthy pregnant subjects were identified by direct sequencing. The correlation between the rs7579169 genotype and the susceptibility to preeclampsia was evaluated using an unconditional logistic regression model. Although there were no differences of having the rs7579169 SNP between early onset and late onset preeclampsia, patients carrying the CT or TT genotype were more likely to develop preeclampsia than those carrying the CC genotype (CT vs CC: OR = 1.76, 95%CI = 1.07-2.87, P < 0.05; TT vs CC: OR = 5.03, 95%CI = 1.99-12.73, P < 0.05; CC vs CT + TT: OR = 2.05, 95%CI = 1.27-3.30, P < 0.05). In conclusion, although no differences of the rs7579169 SNP were identified between the early onset and late onset preeclampsia groups, we found that the CT or TT genotype and the CT+TT genotype were significantly associated with an increased risk of preeclampsia in Han Chinese women.
INTRODUCTION
Preeclampsia is a heterogeneous group of disorders in pregnancy with de novo hypertension and proteinuria occurring after the 20th gestational week and is characterized by hypertension and proteinuria, with or without edema (Haram et al., 2014) . As one of the most common pregnancy complications, preeclampsia is a mainly cause of high mortality and morbidity of both mother and child (Aali et al., 2004; Langenveld et al., 2011) . Nowadays, more studies have focused on the subject of genetic conditioning of preeclampsia, but the etiology of preeclampsia is still unknown (Molvarec et al., 2008) .
Single nucleotide polymorphisms (SNPs) can be an insertion, deletion, or substitution point mutation in the coding or noncoding DNA sequence (Kuśmierska-Urban et al., 2015) , with an increasing number being identified to associate with risks and prognoses of human diseases (Shastry, 2009) . A genome-wide association study (GWAS) of preeclampsia had reported a risk locus on chromosome 2q14 (Johnson et al., 2012) ; subsequently, the SNP rs7579169, located on chromosome 2q14.2, has been shown to be associated with pregnancyinduced hypertension in Europeans (Kuśmierska-Urban et al., 2015) . In this study, we aimed to identify the association between preeclampsia and the SNP rs7579169 in a cohort of Han Chinese women.
MATERIAL AND METHODS

Study subjects
The study subjects consisted of 145 patients with preeclampsia and 150 healthy pregnant subjects, randomly selected from the Suzhou Xiangcheng People's Hospital between 2009 and 2015. Preeclampsia is defined as gestational hypertension with proteinuria (the presence of blood pressure values ³140/90 mmHg on two measurements at least 6 h apart; 24 h urinary protein ³300 mg or a protein-positive urine dipstick test) after the 20th week of pregnancy in a previously normotensive and non-proteinuric woman (Wan et al., 2013) . Patients with multiple pregnancies, fetal anomalies, and with renal, liver, or heart diseases were excluded. Each patient was interviewed and a detailed medical history such as gravidity, parity, fetal weight, pre-pregnancy body mass index (pre-BMI), and week of gestation was taken. Early-onset preeclampsia was defined as manifestation before 34 gestational weeks and late-onset preeclampsia as thereafter.
After written consent, peripheral vein blood was obtained from each study subject. The protocol was approved by the Ethics Committee of the Suzhou Xiangcheng People's Hospital.
DNA extraction and genotyping
Wizard Genomic DNA Purification Kit (Promega, Madison, WI, USA) was used to extract genomic DNA from peripheral blood and tumor tissues, respectively (Shen et al., 2015) . After PCR amplication, the products were sequenced directly by ABI 3730. The primers were: forward primer: 5'-CTGCTCTATGGCTTCCCAAG-3'; reverse primer: 5'-TGAGCGAACTCAGGCACA-3'. The PCR conditions were: 95°C for 5 min, then 40 cycles at 95°C for 30 s, 55°C for 30 s, and 72°C for 30 s, followed by 72°C for 5 min (Kuśmierska-Urban et al., 2015) .
Statistical analysis
The SAS version 17.0 software was used for statistical analysis (SAS Institute, Cary, NC, USA). All statistical tests were two-sided, and differences were considered to be statistically significant when P < 0.05. Furthermore, after adjusted by age and gender, odds ratios (ORs) and 95% confidence intervals (95%CI) from a non-conditional logistic regression model were used to estimate the association between rs7579169 genotypes and susceptibility to preeclampsia.
RESULTS
Characteristics of cases
Included in this study were 145 patients with preeclampsia (81 were early-onset, 64 were late-onset) and 150 healthy pregnant subjects. The characteristics of the subjects are shown in Table 1 . Maternal age, pre-BMI and primiparas were matched in case and control groups (P > 0.05). SBP (systolic blood pressure) and DBP (diastolic blood pressure) were higher in the case group than in the control group (SBP: 160.5 ± 20.5 vs 111.5 ± 9.8; DBP: 108.1 ± 13.3 vs 78.6 ± 6.7 mmHg). Due to preeclampsia, delivery weeks were early in the case group than in the control group (35.8 ± 2.9 vs 39.5 ± 1.2). Fetal weight was lower in the case group than in the control group (2548.6 ± 955.4 vs 3403.2 ± 564.9 g). 
Genotyping and association analysis
Genotyping of the rs7579169 SNP from all samples was successfully determined by direct sequencing. After analysis with the Hardy-Weinberg equilibrium (P = 0.4591 and 0.1281, respectively), all data were used for further analysis.
As shown in Table 2 , in the preeclampsia group, 45/145 (31.0%) were CC homozygotic, 78/145 (53.8%) were CT heterozygotic, while 22/145 (15.2%) were TT homozygotic. In control samples, the frequency of the CC, CT, and TT genotypes were 48, 47.3, and 4.7%, respectively. By logistic regression analysis, we found significant differences in susceptibility to preeclampsia (CT vs CC: OR = 1.76, 95%CI = 1.07-2.87, P < 0.05; TT vs CC: OR = 5.03, 95%CI = 1.99-12.73, P < 0.05; CC vs CT + TT: OR = 2.05, 95%CI = 1.27-3.30, P < 0.05). Furthermore, in the early-onset preeclampsia group, 23/81 (28.4%) were CC homozygotic, 43/81 (53.1%) were CT heterozygotic, while 15/81 (18.5%) were TT homozygotic. In the late-onset group, the frequency of the CC, CT, and TT genotypes were 34.4, 54.6, and 7%, respectively. No significant differences were found between the early onset and late-onset group (Table 3) . 
DISCUSSION
Preeclampsia is currently recognized as a syndrome rather than as a definite disease. Approximately 2.5 to 3% of all pregnancies are affected and preeclampsia is a leading cause of maternal morbidity and mortality in developing countries (Sibai et al., 1993; de Swiet, 2000) . Despite intensive research efforts, the etiology and pathogenesis of preeclampsia are still not fully understood. Increasing evidence suggests that chronic hypertension, renal diseases, obesity and insulin resistance, diabetes mellitus, preexisting thrombophilia, family history of preeclampsia, smoking and high BMI were associated with preeclampsia. As the essential hypertension (EH), preeclampsia was also thought to be a multifactorial disorder that develops due to an interaction of hereditary and environmental factors. Many possible susceptibility genes were reported, such as angiotensin, angiotensin-type 1 receptor, endothelial nitric oxide synthase, estrogen receptor β, apolipoprotein E, lipoprotein lipase, and methylenetetrahydrofolate reductase (Nakayama and Yamamoto, 2009) .
In our study, we found that the rs7579169 SNP was associated with preeclampsia in Han Chinese women. The rs7579169 SNP is located on chromosome 2q14.2, and it has been reported to be associated with preeclampsia in an Australian population (Johnson et al., 
